Firsthand Technology Value Fund Discloses Top Portfolio Holdings
As of July 31, 2022, Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings, representing 93.2% of estimated total investments of approximately $50.2 million, or $7.28 per share. Key holdings include:
- IntraOp Medical (32.6%)
- Wrightspeed (31.4%)
- Revasum (15.8%)
- Hera Systems (11.2%)
- EQX Capital (2.3%)
The Fund focuses on investments in technology and cleantech companies.
- Top five holdings represent 93.2% of total investments.
- Estimated total investments of approximately $50.2 million.
- Focus on technology and cleantech sectors.
- None.
SAN JOSE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of July 31, 2022, were IntraOp Medical, Wrightspeed, Revasum, Hera Systems, and EQX Capital.
- IntraOp Medical Corp. is the manufacturer of the Mobetron, a medical device that is used to deliver intra-operative radiation to cancer patients. As of July 31, 2022, the Fund’s investment in IntraOp consisted of preferred stock plus debt securities and represented approximately
32.6% of the Fund’s estimated total investments.* - Wrightspeed, Inc. is a supplier of electric drivetrains for heavy-duty commercial vehicles. As of July 31, 2022, the Fund’s investment in Wrightspeed consisted of preferred stock plus debt securities and represented approximately
31.4% of the Fund’s estimated total investments.* - Revasum, Inc. (ASX: RVS) is a provider of chemical-mechanical planarization (CMP) and grinding tools to the semiconductor industry. As of July 31, 2022, the Fund’s investment in Revasum consisted of common stock equivalents (CDI’s) and represented approximately
15.8% of the Fund’s estimated total investments.* - Hera Systems, Inc. is developing micro satellites with imaging and communication capabilities for launch into low Earth orbit. As of July 31, 2022, the Fund’s investment in Hera consisted of preferred stock plus debt securities and warrants to purchase additional shares and represented approximately
11.2% of the Fund’s estimated total investments.* - EQX Capital, Inc. provides equipment financing solutions to technology companies and their customers. As of July 31, 2022, the Fund’s investment in EQX consisted of preferred and common stock and represented approximately
2.3% of the Fund’s estimated total investments.*
The Fund also announced that as of July 31, 2022, the estimated total investments* of the Fund were approximately
*Total investments are estimated as of July 31, 2022, and represent the value of the Fund’s total investments as of June 30, 2022, plus the estimated net change in unrealized appreciation/depreciation and actual realized gains/losses on publicly traded and private securities since June 30, 2022. For the purposes of calculating the percentage of estimated total investments represented by each investment, the value of each holding is determined by either: (1) the purchase price, (2) the market value for public securities, less any discounts taken due to restrictions on the stock, or (3) the June 30, 2022, fair value of each security, as determined under procedures approved by our Board of Directors. The estimated total investments figure does not reflect net asset value because actual and estimated liabilities (such as estimated tax liabilities and performance fees, accrued vendor service fees and other liabilities) are not deducted.
About Firsthand Technology Value Fund
Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com.
The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us.
Contact:
Phil Mosakowski
Firsthand Capital Management, Inc.
(408) 624-9526
vc@firsthandtvf.com
FAQ
What are the top holdings of Firsthand Technology Value Fund (SVVC)?
What percentage of the total investments does IntraOp Medical represent for SVVC?
What is the estimated total investments of Firsthand Technology Value Fund (SVVC)?
When will the financial statements for SVVC be available?
What investment areas does Firsthand Technology Value Fund focus on?
